Alan T Hirsch Selected Research

Alan T Hirsch Research Topics

Disease

34	Peripheral Arterial Disease 01/2018 - 01/2003
14	Myocardial Infarction 01/2021 - 05/2003
13	Stroke (Strokes) 01/2021 - 12/2006
11	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 01/2009
9	Intermittent Claudication 04/2017 - 05/2003
7	Thrombosis (Thrombus) 09/2010 - 12/2006
6	Hypertension (High Blood Pressure) 06/2009 - 11/2003
5	Atherosclerosis 01/2018 - 01/2002
5	Chronic Limb-Threatening Ischemia 01/2018 - 11/2011
5	Vascular Diseases (Vascular Disease) 02/2010 - 06/2004
4	Ischemia 10/2014 - 02/2004
4	Coronary Disease (Coronary Heart Disease) 04/2008 - 01/2002
3	Pain (Aches) 01/2018 - 10/2015
3	Hemorrhage 12/2015 - 11/2008
3	Neoplasms (Cancer) 11/2015 - 11/2011
3	Diabetes Mellitus 02/2010 - 09/2002
2	Heart Failure 11/2016 - 11/2008
2	Cellulitis 11/2015 - 01/2014
2	Lymphedema (Milroy Disease) 11/2015 - 01/2014
2	Wounds and Injuries (Trauma) 10/2012 - 11/2011
2	Atrial Fibrillation 02/2010 - 11/2008
2	Coronary Artery Disease (Coronary Atherosclerosis) 02/2010 - 04/2008
2	Ischemic Stroke 12/2006 - 02/2004
1	Albuminuria 11/2016
1	Kidney Diseases (Kidney Disease) 11/2016
1	Renal Artery Obstruction (Renal Artery Stenosis) 11/2016
1	Renal Insufficiency (Renal Failure) 11/2016
1	Mobility Limitation (Difficulty Walking) 01/2016
1	Edema (Dropsy) 10/2015
1	Breast Neoplasms (Breast Cancer) 10/2015
1	Dizziness (Lightheadedness) 08/2014
1	Hypoxia (Hypoxemia) 08/2014
1	Abdominal Obesity 11/2012
1	Hyperlipidemias (Hyperlipidemia) 04/2012
1	Hypercholesterolemia 04/2012
1	Carotid Artery Diseases 09/2010
1	Flushing 06/2010
1	Dyslipidemias (Dyslipidemia) 06/2009
1	Heart Diseases (Heart Disease) 10/2008
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 02/2007
1	Transient Ischemic Attack 12/2006

Drug/Important Bio-Agent (IBA)

10	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021 - 09/2002
5	CholesterolIBA 04/2012 - 12/2006
4	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 01/2006
4	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 09/2011 - 01/2006
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 06/2010 - 01/2006
3	Fibrinogen (Factor I)FDA Link 10/2009 - 02/2007
3	LipidsIBA 10/2009 - 06/2005
2	TroponinIBA 01/2018 - 08/2014
2	AlbuminsIBA 01/2018 - 11/2016
2	Folic Acid (Vitamin M)FDA LinkGeneric 01/2016 - 11/2012
2	Vitamin D FDA LinkGeneric 01/2016 - 11/2012
2	AnticoagulantsIBA 09/2011 - 11/2008
2	Pharmaceutical PreparationsIBA 11/2008 - 01/2003
2	von Willebrand FactorIBA 11/2007 - 02/2007
2	Factor VIII (Coagulation Factor VIII)IBA 11/2007 - 02/2007
2	Clopidogrel (Plavix)FDA Link 02/2004 - 09/2002
1	1,5-anhydroglucitolIBA 01/2018
1	FructosamineIBA 01/2018
1	Natriuretic PeptidesIBA 01/2018
1	pro-brain natriuretic peptide (1-76)IBA 01/2018
1	Troponin T (Troponin T1)IBA 01/2018
1	Hemoglobins (Hemoglobin)IBA 01/2018
1	Aldehyde DehydrogenaseIBA 04/2017
1	hydroxide ionIBA 01/2017
1	25-hydroxyvitamin DIBA 01/2017
1	ElementsIBA 01/2017
1	CreatinineIBA 11/2016
1	CK-2017357IBA 08/2014
1	Blood Glucose (Blood Sugar)IBA 06/2010
1	Lovastatin (Mevacor)FDA LinkGeneric 06/2010
1	Niacin (Nicotinic Acid)FDA LinkGeneric 06/2010
1	EnzymesIBA 06/2010
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 02/2010
1	Antihypertensive Agents (Antihypertensives)IBA 06/2009
1	fibrin fragment D (D-dimer)IBA 11/2007
1	Hemostatics (Antihemorrhagics)IBA 11/2007
1	beta-ThromboglobulinIBA 11/2007
1	Plasminogen Activator Inhibitor 1IBA 11/2007
1	Factor VII (Proconvertin)IBA 11/2007
1	Lipoprotein(a)IBA 02/2007

Therapy/Procedure

14	Surgical Amputation (Amputations) 01/2018 - 08/2005
12	Therapeutics 11/2016 - 11/2003
10	Vascular Surgical Procedures 03/2012 - 03/2006
3	Cell- and Tissue-Based Therapy (Cell Therapy) 04/2017 - 11/2014
3	Stents 11/2016 - 01/2012
3	Secondary Prevention 02/2010 - 12/2006
2	Carotid Endarterectomy 09/2010 - 12/2006
2	Patient Readmission 10/2009 - 02/2004
1	Renal Replacement Therapy (Therapies, Renal Replacement) 11/2016
1	Musculoskeletal Manipulations (Manipulative Therapy) 11/2015
1	Ambulatory Care (Outpatient Care) 11/2015
1	Lymph Node Excision (Lymph Node Dissection) 10/2015
1	Intramuscular Injections 11/2014
1	Physical Therapy Modalities (Physical Therapy Technique) 01/2014
1	Drug Therapy (Chemotherapy) 12/2013
1	Catheters 09/2010
1	Contraindications 02/2010
1	Counterpulsation (External Counterpulsation) 02/2010
1	Endarterectomy (Thromboendarterectomy) 12/2006